EA200000350A1 - METHOD OF OBTAINING 3-ARYLOXY, 4-ARYLFURAN-2-ONES, USEFUL AS A CYCLOOXYGENASE-2 INHIBITORS - Google Patents

METHOD OF OBTAINING 3-ARYLOXY, 4-ARYLFURAN-2-ONES, USEFUL AS A CYCLOOXYGENASE-2 INHIBITORS

Info

Publication number
EA200000350A1
EA200000350A1 EA200000350A EA200000350A EA200000350A1 EA 200000350 A1 EA200000350 A1 EA 200000350A1 EA 200000350 A EA200000350 A EA 200000350A EA 200000350 A EA200000350 A EA 200000350A EA 200000350 A1 EA200000350 A1 EA 200000350A1
Authority
EA
Eurasian Patent Office
Prior art keywords
useful
obtaining
cyclooxygenase
inhibitors
ones
Prior art date
Application number
EA200000350A
Other languages
Russian (ru)
Other versions
EA002690B1 (en
Inventor
Ченг Й. Чен
Роберт Д. Ларсен
Луши Тан
Original Assignee
Мерк Энд Ко., Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9815805.8A external-priority patent/GB9815805D0/en
Application filed by Мерк Энд Ко., Инк. filed Critical Мерк Энд Ко., Инк.
Publication of EA200000350A1 publication Critical patent/EA200000350A1/en
Publication of EA002690B1 publication Critical patent/EA002690B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60Two oxygen atoms, e.g. succinic anhydride

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Описан способ получения 3-арил, 4-арилоксифуран-5-онов, которые являются полезными в качестве ингибиторов циклооксигеназы-2 (COX-2). Такие соединения являются полезными в качестве противовоспалительных агентов. Способ направлен на асимметричный синтез, который включает: получение тризамещенных производных стирола реакцией Хорнера-Ведсворта-Эммонса с последующим в одном сосуде трифторметилированием аллилового спирта; получение α-гидроксикетона с использованием асимметричного дигидроксилирования Шарплесса и окисления Сверна; эстерификацию α-гидроксикетона феноксиуксусной кислотой и конденсацию Дайкмана полученного в результате сложного эфира.Международная заявка была опубликована вместе с отчетом о международном поиске.A method for producing 3-aryl, 4-aryloxyfuran-5-ones, which are useful as inhibitors of cyclooxygenase-2 (COX-2), is described. Such compounds are useful as anti-inflammatory agents. The method is aimed at asymmetric synthesis, which includes: obtaining trisubstituted derivatives of styrene by the Horner-Westsworth-Emmons reaction followed by trifluoromethylation of allyl alcohol in one vessel; obtaining α-hydroxyketone using asymmetric Sharpless dihydroxylation and Swern oxidation; esterification of α-hydroxyketone with phenoxyacetic acid and Dyckman condensation of the resulting ester. The international application was published together with an international search report.

EA200000350A 1997-09-24 1998-09-21 Process of making 3-aryloxy, 4-aryl furan-2-ones useful as inhibitors of cox-2 EA002690B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6069497P 1997-09-24 1997-09-24
GBGB9815805.8A GB9815805D0 (en) 1998-07-21 1998-07-21 Chemical process
PCT/US1998/019642 WO1999015513A1 (en) 1997-09-24 1998-09-21 Process of making 3-aryloxy, 4-aryl furan-2-ones useful as inhibitors of cox-2

Publications (2)

Publication Number Publication Date
EA200000350A1 true EA200000350A1 (en) 2000-10-30
EA002690B1 EA002690B1 (en) 2002-08-29

Family

ID=26314074

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000350A EA002690B1 (en) 1997-09-24 1998-09-21 Process of making 3-aryloxy, 4-aryl furan-2-ones useful as inhibitors of cox-2

Country Status (7)

Country Link
EP (1) EP1017687A4 (en)
JP (1) JP3516658B2 (en)
CN (1) CN1271352A (en)
AU (1) AU2247599A (en)
EA (1) EA002690B1 (en)
SK (1) SK4202000A3 (en)
WO (1) WO1999015513A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001232175B2 (en) 2000-03-03 2005-07-07 Pfizer Products Inc. Pyrazole ether derivatives as anti-inflammatory/analgesic agents
HUP0302068A3 (en) 2000-07-20 2005-05-30 Lauras As Use of cox-2 inhibitors for treating or preventing immunodeficiency and pharmaceutical compositions containing them

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352832A (en) * 1992-12-18 1994-10-04 Schering Corporation Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates
US5393790A (en) * 1994-02-10 1995-02-28 G.D. Searle & Co. Substituted spiro compounds for the treatment of inflammation
UA57002C2 (en) * 1995-10-13 2003-06-16 Мерк Фросст Кенада Енд Ко./Мерк Фросст Кенада Енд Сі. (methylsulfonyl)phenyl-2-(5n)-furanon derivative, a pharmaceutical composition and a method for treatment
US5789413A (en) * 1996-02-01 1998-08-04 Merck Frosst Canada, Inc. Alkylated styrenes as prodrugs to COX-2 inhibitors

Also Published As

Publication number Publication date
EP1017687A1 (en) 2000-07-12
JP2001517661A (en) 2001-10-09
WO1999015513A1 (en) 1999-04-01
SK4202000A3 (en) 2000-10-09
AU2247599A (en) 1999-04-12
EP1017687A4 (en) 2001-10-31
JP3516658B2 (en) 2004-04-05
EA002690B1 (en) 2002-08-29
CN1271352A (en) 2000-10-25

Similar Documents

Publication Publication Date Title
EA200000350A1 (en) METHOD OF OBTAINING 3-ARYLOXY, 4-ARYLFURAN-2-ONES, USEFUL AS A CYCLOOXYGENASE-2 INHIBITORS
Chamberlin et al. Stereoselective methylation of β-hydroxylactone dianions
BR8004276A (en) ACETYLACETOXYL-ALYL ALYL ETERS, PROCESS FOR ITS PRODUCTION, AND ITS APPLICATION
ATE9225T1 (en) DERIVATIVES OF 5-HYDROXY-TETRAHYDRO-2-FURANONE.
Mattingly et al. Chiral synthesis of protected 3-amino-4-(alkoxycarbonyl)-2-azetidinones from. beta.-hydroxyaspartic acid
DK0909751T3 (en) Process for the preparation of cinnamic acid esters
KR840001120A (en) Method for preparing acrylic acid ester or methacrylic acid ester
EP1336601A4 (en) Process for preparing fluorinated esters by gas chromatography
KR970015557A (en) Esterification method of (meth) acrylic acid with alkanol
JPS5432456A (en) Preparation of jasmonic acid analogue
IT1262455B (en) PROCEDURE FOR THE PREPARATION OF A CATALYST FOR THE PRODUCTION OF EVIL ANHYDRIDE BY BUTANE OXIDATION.
EA200100733A1 (en) METHOD FOR OBTAINING GLYOXYLIC ACID ESTERS OR THEIR HYDRATES
ES2169891T3 (en) PROCEDURE FOR THE PRODUCTION OF ALCOXICARBONYLTIOARILY COMPOUNDS.
KR900701726A (en) Tri-substituted benzoic acid intermediate
JPS53147018A (en) Preparation of carboxylic acid glycidyl ester
ES490769A0 (en) PROCEDURE FOR OBTAINING SUBSTITUTED ESTIRIL-CYCLOPROPANCARBOXYL ACID ESTERS, WITH AN INSECTICIDE AND ACARICIDE EFFECT
CH609027A5 (en) New process for the preparation of lower alkyl esters of hemicaronaldehyde (hemicaronic aldehyde)
WO2002062781A1 (en) Preparation of isocoumarin derivatives and intermediates for the synthesis thereof
ATE532764T1 (en) PRODUCTION OF TRIMETHYLHYDROCHINONDIACYLATES
BR9812509A (en) Process for producing compounds
KR910011869A (en) Crystalline magnesium valproate and preparation method thereof
EP1203616A4 (en) Chiral lead catalyst and method of asymmetric aldol reaction
Curci et al. Synthesis of functionalized acrylates
JPS53108922A (en) Novel synthesis of opticallactive hydroxyacid
GB1462407A (en) Preparation of p-isobutyl hydratropic acid and intermediates therefor

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU